- Home
- CNTA vs FIHL Comparison
CNTA vs FIHL Comparison
Compare CNTA & FIHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNTA | FIHL |
|---|---|---|
| Founded | 2020 | 2014 |
| Country | United Kingdom | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | 2021 | 2023 |
Fundamental Metrics
Financial Performance| Metric | CNTA | FIHL |
|---|---|---|
| Price | $29.84 | $18.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 7 |
| Target Price | ★ $35.00 | $21.14 |
| AVG Volume (30 Days) | ★ 2.1M | 545.4K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,000,000.00 | ★ $2,573,400,000.00 |
| Revenue This Year | N/A | $9.83 |
| Revenue Next Year | N/A | $9.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 118.88 | 11.89 |
| 52 Week Low | $9.60 | $14.17 |
| 52 Week High | $30.00 | $20.44 |
Technical Indicators
Market Signals| Indicator | CNTA | FIHL |
|---|---|---|
| Relative Strength Index (RSI) | 68.32 | 41.63 |
| Support Level | $28.19 | $18.43 |
| Resistance Level | $29.77 | $19.33 |
| Average True Range (ATR) | 1.35 | 0.40 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 91.58 | 17.81 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a specialty insurer that leverages strategic partnerships to offer tailored insurance solutions. The company classifies its business into two segments, Insurance and Reinsurance. A majority of its revenue is generated from the Insurance segment, which comprises a portfolio of property, marine, aviation and aerospace, political risk, violence and terror, energy, cyber, and other insurance risks. The Reinsurance segment consists of an actively managed property reinsurance book, providing reinsurance and a limited amount of retrocession coverage across the world on a proportional or excess-of-loss basis. Geographically, the company derives its key revenue from the United Kingdom, followed by Bermuda and the Republic of Ireland.